ValiRx plc's market cap is currently ―. The company's EPS TTM is p-0.025; its P/E ratio is -1.62; ValiRx plc is scheduled to report earnings on April 9, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Dec 21	Jun 21	Dec 20	Jun 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 97.70K	£ 593.67K	£ 1.24M	£ 1.85M	£ 258.75K
Total Assets	£ 3.00M	£ 3.52M	£ 4.15M	£ 4.94M	£ 3.80M
Total Debt	£ 47.38K	£ 58.72K	£ 67.27K	£ 71.06K	£ 243.78K
Net Debt	£ -50.32K	£ -534.95K	£ -1.17M	£ -1.78M	£ -14.97K
Total Liabilities	£ 329.33K	£ 109.56K	£ 127.77K	£ 182.40K	£ 1.02M
Stockholders Equity	£ 2.87M	£ 3.60M	£ 4.19M	£ 4.91M	£ 2.94M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in GBP

ValiRx plc Earnings and Revenue History

Income Statement >

ValiRx plc Debt to Assets

Balance Sheet >

ValiRx plc Cash Flow

Cash Flow >

ValiRx plc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing